Next Day Disclosure Return
Filed with HKEX · Stock code 1548 · · 7 pages · English
Genscript Biotech Corporation on 6ix
Earlier from Genscript Biotech
- Completion of placing of new shares under the general mandate
- GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
- GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
- GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Later from Genscript Biotech
- Interim report 2026
- Passing away of an independent non-executive director and change in composition of board committees
- List of directors and their role and function
- Announcement pursuant to rule 13.10 of the listing rules
- Change in board lot size
Follow Genscript Biotech into a list and get an email when it puts out news.
Follow Genscript Biotech